In a pivotal year-end strategic push, Profusa (NASDAQ: PFSA) announced two major milestones that signal a shift from a clinical-stage…
Read More »
Profusa (NASDAQ: PFSA), a commercial-stage digital health company, solidified its position in the biochemical monitoring market this week after presenting…
Read More »
The last four months proved transformative for Profusa (NASDAQ: PFSA). The company emerged from a whirlwind of activity with a…
Read More »
In a rare and powerful show of bipartisan force, Congress overwhelmingly approved legislation this week demanding the public release of…
Read More »
Digital health company Profusa (NASDAQ: PFSA) recently laid out one of the most ambitious commercial roadmaps the biosensor sector has…
Read More »
Berkeley-based digital health innovator Profusa (NASDAQ: PFSA) just cleared a major hurdle on its path to commercialization. The company announced…
Read More »
Armata Pharmaceuticals (NYSE American: ARMP) surprised Wall Street on Wednesday after its stock rocketed as much as 370% intraday on…
Read More »
Bakkt Holdings (NYSE: BKKT) delivered another jolt to Wall Street this week, with its stock price surging after Benchmark more…
Read More »
Profusa (NASDAQ: PFSA) is quickly building momentum across Europe, adding leading vascular specialists to its clinical network while also preparing…
Read More »
Shares of Bullish (NYSE: BLSH) delivered one of the year’s most explosive market debuts on Wednesday, instantly transforming its co-founders,…
Read More »